Mitral bioprosthetic valve MITRIS RESILIA mitral

nitinol

As your trusted partner in cardiac surgery innovation, Edwards Lifesciences has developed the MITRIS RESILIA mitral valve to help meet the specialized needs of your patients. When replacement is the best choice, what if you had an option designed to be similar to the native valve? Created for it Developed with your patient's quality of life in mind Looks like it A saddle-shaped sewing cuff mimics the native mitral annulus Performs like it Handles the pressure of the mitral position Built on the Carpentier-Edwards PERIMOUNT valve platform a platform with over 20 years of published clinical durability.1 Cobalt chromium bands provide good visibility under fluoroscopy for easy identification of the landing zone for potential future transcatheter interventions. Dry storage to eliminate need for rinsing. Lowest profile stents do not obstruct blood flow through the left ventricular outflow tract (LVOT). ^On a label size 25 mm. Anterior Profile Height. An enhanced delivery experience A posteromedial commissure mark (single black line), an anterolateral commissure mark (double black line), and an anterior segment mark (“A”mark). The black commissure markers facilitate the orientation of the valve and help avoid obstruction of the left ventricular outflow tract by stent posts. Nitinol stents fold down to 55 degrees, allowing for ease of implant; stents return to original position when valve is implanted. RESILIA tissue clinical data: Backed by a strong and growing body of clinical evidence supporting RESILIA tissue’s ongoing study of durability and hemodynamic performance 2, 3, 4